AstraZeneca beats second-quarter profit expectations, maintains outlook
(Reuters) -AstraZeneca (AZN) beat second-quarter earnings expectations on Tuesday, helped by strong sales of key cancer, heart and kidney disease ...
Read moreDetailsTag: drug pipeline
- Trending
- Comments
- Latest
